These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 25928274

  • 1. Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.
    Percy CL, Hartmann R, Jones RM, Balachandran S, Mehta D, Dockal M, Scheiflinger F, O'Donnell VB, Hall JE, Collins PW.
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):357-67. PubMed ID: 25928274
    [Abstract] [Full Text] [Related]

  • 2. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD, Leong T, Tanaka KA.
    Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
    [Abstract] [Full Text] [Related]

  • 3. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
    Franklin SW, Szlam F, Fernandez JD, Leong T, Tanaka KA, Guzzetta NA.
    Anesth Analg; 2016 Apr; 122(4):935-42. PubMed ID: 26599794
    [Abstract] [Full Text] [Related]

  • 4. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E, Heitmeier S, Laux V, Buchmüller A.
    Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
    [Abstract] [Full Text] [Related]

  • 5. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T, Gando S, Kemmotsu O, Mashio H, Goda Y, Kawahigashi H, Watanabe N.
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [Abstract] [Full Text] [Related]

  • 6. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
    Takeshita S, Ogawa S, Nakayama Y, Mukai N, Nakajima Y, Mizobe T, Sawa T, Tanaka KA.
    Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
    [Abstract] [Full Text] [Related]

  • 7. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.
    Lindahl TL, Wallstedt M, Gustafsson KM, Persson E, Hillarp A.
    Thromb Res; 2015 Mar; 135(3):544-7. PubMed ID: 25596769
    [Abstract] [Full Text] [Related]

  • 8. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B, Ingerslev J.
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [Abstract] [Full Text] [Related]

  • 9. Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery.
    Tanaka KA, Mazzeffi MA, Strauss ER, Szlam F, Guzzetta NA.
    J Anesth; 2016 Jun; 30(3):369-76. PubMed ID: 26749482
    [Abstract] [Full Text] [Related]

  • 10. A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding.
    Kremers RM, Bosch YP, Bloemen S, de Laat B, Weerwind PW, Mochtar B, Maessen JG, Wagenvoord RJ, Al Dieri R, Hemker HC.
    Thromb Haemost; 2016 Aug 30; 116(3):442-51. PubMed ID: 27121983
    [Abstract] [Full Text] [Related]

  • 11. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M, Fenger-Eriksen C, Wierup P, Greisen J, Ingerslev J, Hjortdal V, Sørensen B.
    Thromb Res; 2017 Jun 30; 154():73-79. PubMed ID: 28437748
    [Abstract] [Full Text] [Related]

  • 12. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
    Sørensen B, Asvaldsdottir HS, Gudmundsdottir BR, Onundarson PT.
    Thromb Res; 2009 Dec 30; 124(6):695-700. PubMed ID: 19733387
    [Abstract] [Full Text] [Related]

  • 13. Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery.
    Bosch YP, Al Dieri R, ten Cate H, Nelemans PJ, Bloemen S, de Laat B, Hemker C, Weerwind PW, Maessen JG, Mochtar B.
    Thromb Res; 2014 Mar 30; 133(3):488-94. PubMed ID: 24388571
    [Abstract] [Full Text] [Related]

  • 14. Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery.
    Maroney SA, Peterson JA, Zwifelhofer W, Martinez ND, Yan K, Bercovitz RS, Woods RK, Mast AE.
    Thromb Haemost; 2018 Sep 30; 118(9):1545-1555. PubMed ID: 30086574
    [Abstract] [Full Text] [Related]

  • 15. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C, Gruenwald CE, Holtby HM, Brandão LR, Chan AK, Van Arsdell GS, McCrindle BW.
    J Thorac Cardiovasc Surg; 2016 Feb 30; 151(2):444-50. PubMed ID: 26553458
    [Abstract] [Full Text] [Related]

  • 16. Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model.
    Grottke O, van Ryn J, Spronk HM, Rossaint R.
    Crit Care; 2014 Feb 05; 18(1):R27. PubMed ID: 24499559
    [Abstract] [Full Text] [Related]

  • 17. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S, Hiramatsu Y, Matsuzaki K, Goto Y, Sato S, Abe M, Kato H, Matsubara M, Sakakibara Y.
    J Card Surg; 2014 Jan 05; 29(1):35-40. PubMed ID: 24266905
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
    Ogawa S, Szlam F, Ohnishi T, Molinaro RJ, Hosokawa K, Tanaka KA.
    Thromb Haemost; 2011 Dec 05; 106(6):1215-23. PubMed ID: 22071880
    [Abstract] [Full Text] [Related]

  • 19. Protocol for a phase 3, randomised, active-control study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients requiring coagulation factor replacement: the LEX-211 (FARES-II) trial.
    Karkouti K, Callum J, Bartoszko J, Solomon C, Knaub S, Levy JH, Tanaka KA, FARES-II Study Group.
    BMJ Open; 2024 Aug 21; 14(8):e091381. PubMed ID: 39174056
    [Abstract] [Full Text] [Related]

  • 20. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
    Kozek-Langenecker SA, Wanzel O, Berger R, Kettner SC, Coraim F.
    Anesth Analg; 1998 Nov 21; 87(5):985-8. PubMed ID: 9806669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.